Cleared Traditional

Pocguide Multi-Drug Test Panel, Pocguide Multi-Drug Test Panel OTC (K242498) - FDA 510(k) Clearance

Class II Toxicology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K242498 · Aicheck Biotech, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2024
Decision
40d
Days
Class 2
Risk

K242498 is an FDA 510(k) clearance for the Pocguide Multi-Drug Test Panel, Pocguide Multi-Drug Test Panel OTC. Classified as Test, Amphetamine, Over The Counter (product code NFT), Class II - Special Controls.

Submitted by Aicheck Biotech, Inc. (Irvine, US). The FDA issued a Cleared decision on October 1, 2024 after a review of 40 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3100 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Aicheck Biotech, Inc. devices

Submission Details

510(k) Number K242498 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 22, 2024
Decision Date October 01, 2024
Days to Decision 40 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 87d · This submission: 40d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NFT Test, Amphetamine, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Consultant

Shanghai SUNGO Management Consulting Co., Ltd.
Dylan Wu

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NFT Test, Amphetamine, Over The Counter

All 28
Devices cleared under the same product code (NFT) and FDA review panel - the closest regulatory comparables to K242498.
AllTest Multi-Drug Rapid Urine Test Cup
K250727 · Hangzhou AllTest Biotech Co., Ltd. · Apr 2025
AllTest Multi-Drug Rapid Test Cup
K244043 · Hangzhou AllTest Biotech Co., Ltd. · Feb 2025
AssureTech Panel Dip Tests
K243996 · Assure Tech., LLC · Feb 2025
AllTest Multi-Drug Urine Test Panel
K242540 · Hangzhou AllTest Biotech Co., Ltd. · Sep 2024
PocguideTM Multi-Drug Test Cup OTC, PocguideTM Multi-Drug Test Cup
K242077 · Aicheck Biotech, Inc. · Aug 2024
AllTest Multi-Drug Urine Test Cup
K241428 · Hangzhou AllTest Biotech Co., Ltd. · Jun 2024